References
- Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2004;84:1–12.
- American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013.
- Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008;8:147–156.
- Kilberg MS, Hutson SG, Laine RO. Amino acid-regulated gene expression in eukaryotic cells. FASEB J 1994;8:13–19.
- Richards NG, Kilberg MS. Asparagine synthetase chemotherapy. Annu Rev Biochem 2006;75:629–654.
- Sorenmo K, Overley B, Krick E, et al. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol 2010;8:196–208.
- Clarkson B, Krakoff I, Burchenal J, et al. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer 1970;25:279–305.
- Lorenzi PL, Reinhold WC, Rudelius M, et al. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther 2006;5:2613–2623.
- Lorenzi PL, Llamas J, Gunsior M, et al. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther 2008;7:3123–3128.
- Krejci O, Starkova J, Otova B, et al. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia 2004;18:434–441.
- Story MD, Voehringer DW, Stephens LC, et al. L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharamcol 1993;32:129–133.
- Ueno T, Ohtawa K, Mitsui K, et al. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia 1997;11: 1858–1861.
- Li BS, Gu LJ, Luo CY, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L-asparaginase. Leukemia 2006;20:2199–2201.
- Su N, Pan YX, Zhou M, et al. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines. Pediatr Blood Cancer 2008;50:274–279.
- Abbatiello SE, Pan YX, Ahou M, et al., Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. J Proteom 2008;71:61–70.
- Appel IM, den Boer ML, Meijerink JP, et al. Up-regulation of asparagine synthetase expression is not linked to the clinical response to L-asparaginase in pediatric acute lymphoblastic leukemia. Blood 2006;107:4244–4249.
- Nakaichi M, Taura Y, Kanki M, et al. Establishment and characterization of a new canine B-cell leukemia cell line. J Vet Med Sci 1996;58:469–471.
- Suter SE, Small GW, Seiser EL, et al. FLT3 mutations in canine acute lymphocytic leukemia. BMC Cancer 2011;11:38.
- Momoi Y, Okai Y, Watari T, Goitsuka R, Tsuimoto H, Hasegawa A. Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Vet Immunol Immunopathol. 1997;59:11–20.
- Kisseberth WC, Nadella MV, Breen M, et al. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research. Leuk Res 2007;31:1709–1720.
- Suter SE, Chein MB, von Messling V, et al. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma. Clin Cancer Res 2005;11:1579–1587.
- Seiser EL, Thomas R, Richards KL, et al. Reading between the lines: molecular characterization of five widely utilized canine lymphoid tumor cell lines. Vet Comp Oncol 2011;11:30–50.
- R Development Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012.
- de Hoon MJ, Imoto S, Nolan J, et al. Open source clustering software. Bioinformatics 2004;20:1453–1454.
- Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci 1998;95:14863–14868.
- Saldanha AJ. Java Treeview--extensible visualization of microarray data. Bioinformatics 2004;20:3246–3248.
- Colella S, Shen L, Baggerly KA, et al. Sensitive and quantitative universal Pyrosequencing™ methylation analysis of CpG sites. Biotechniques 2003;35:146–150.
- Avramis V, Tiwari PN. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomed 2006;1:241–254.
- Avramis V. Asparaginases: biochemical pharmacology and modes of drug resistance. Anticancer Res 2012;32:2423–2438.
- Yu M, Henning R, Walker A, et al. L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med 2012;16:2369–2378.
- Peng H, Shen N, Qian L, et al. Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells. Br J Cancer 2001;85:930–935.
- Worton KS, Kerbel RS, Andrulis IL. Hypomethylation and reactivation of the asparagine synthetase gene inducced by L-asparaginase and ethyl methanesulfonate. Cancer Res 1991;51: 985–989.
- Akagi T, Yin D, Kawamata N, et al. Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells. Leukemia 2006;20:1303–1306.
- Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Br J Haematol 2005; 130:860–868.
- Matsumoto Y, Nomura K, Kanda-Akano Y, et al. Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma. Leuk Lymphoma 2003;44:879–882.
- Rassnick KM, McEntee MC, Erb HN, et al. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med 2007;21:1364–1373.
- Iwamoto S, Mihara K, Downing JR, et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007;117:1049–1057.